Literature DB >> 26148446

Chronic fatigue syndrome and circulating cytokines: A systematic review.

S Blundell1, K K Ray2, M Buckland3, P D White4.   

Abstract

There has been much interest in the role of the immune system in the pathophysiology of chronic fatigue syndrome (CFS), as CFS may develop following an infection and cytokines are known to induce acute sickness behaviour, with similar symptoms to CFS. Using the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-analyses) guidelines, a search was conducted on PubMed, Web of Science, Embase and PsycINFO, for CFS related-terms in combination with cytokine-related terms. Cases had to meet established criteria for CFS and be compared with healthy controls. Papers retrieved were assessed for both inclusionary criteria and quality. 38 papers met the inclusionary criteria. The quality of the studies varied. 77 serum or plasma cytokines were measured without immune stimulation. Cases of CFS had significantly elevated concentrations of transforming growth factor-beta (TGF-β) in five out of eight (63%) studies. No other cytokines were present in abnormal concentrations in the majority of studies, although insufficient data were available for some cytokines. Following physical exercise there were no differences in circulating cytokine levels between cases and controls and exercise made no difference to already elevated TGF-β concentrations. The finding of elevated TGF-β concentration, at biologically relevant levels, needs further exploration, but circulating cytokines do not seem to explain the core characteristic of post-exertional fatigue.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemokine; Chronic fatigue syndrome; Cytokine; Immune system; Myalgic encephalomyelitis; Pathophysiology; Systematic review; Transforming growth factor-beta

Mesh:

Substances:

Year:  2015        PMID: 26148446     DOI: 10.1016/j.bbi.2015.07.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  47 in total

1.  Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Authors:  L V Clark; M Buckland; G Murphy; N Taylor; V Vleck; C Mein; E Wozniak; M Smuk; P D White
Journal:  Clin Exp Immunol       Date:  2017-10-11       Impact factor: 4.330

Review 2.  A systematic review of the association between fatigue and genetic polymorphisms.

Authors:  Tengteng Wang; Jie Yin; Andrew H Miller; Canhua Xiao
Journal:  Brain Behav Immun       Date:  2017-01-12       Impact factor: 7.217

Review 3.  Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

Authors:  Benjamin Heng; Gilles J Guillemin; Bahar Kavyani; Brett A Lidbury; Richard Schloeffel; Paul R Fisher; Daniel Missailidis; Sarah J Annesley; Mona Dehhaghi
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

4.  Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications.

Authors:  Loredana Raciti; Francesca Antonia Arcadi; Rocco Salvatore Calabrò
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

5.  Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Akiko Eguchi; Sanae Fukuda; Hirohiko Kuratsune; Junzo Nojima; Yasuhito Nakatomi; Yasuyoshi Watanabe; Ariel E Feldstein
Journal:  Brain Behav Immun       Date:  2019-11-20       Impact factor: 7.217

6.  Cytokine signature associated with disease severity in chronic fatigue syndrome patients.

Authors:  Jose G Montoya; Tyson H Holmes; Jill N Anderson; Holden T Maecker; Yael Rosenberg-Hasson; Ian J Valencia; Lily Chu; Jarred W Younger; Cristina M Tato; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

7.  Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.

Authors:  Megan E Roerink; Hans Knoop; Sebastian J H Bredie; Michael Heijnen; Leo A B Joosten; Mihai G Netea; Charles A Dinarello; Jos W M van der Meer
Journal:  Trials       Date:  2015-10-05       Impact factor: 2.279

8.  The International Collaborative on Fatigue Following Infection (COFFI).

Authors:  Ben Z Katz; Simon M Collin; Gabrielle Murphy; Rona Moss-Morris; Vegard Bruun Wyller; Knut-Arne Wensaas; Jeannine L A Hautvast; Chantal P Bleeker-Rovers; Ute Vollmer-Conna; Dedra Buchwald; Renée Taylor; Paul Little; Esther Crawley; Peter D White; Andrew Lloyd
Journal:  Fatigue       Date:  2018-01-19

9.  The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.

Authors:  Natalie Eaton-Fitch; Hélène Cabanas; Stanley du Preez; Donald Staines; Sonya Marshall-Gradisnik
Journal:  J Transl Med       Date:  2021-07-15       Impact factor: 5.531

10.  Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome.

Authors:  Zi-Teng Zhang; Xiu-Ming Du; Xiu-Juan Ma; Ying Zong; Ji-Kuai Chen; Chen-Lin Yu; Yan-Gang Liu; Yong-Chun Chen; Li-Jun Zhao; Guo-Cai Lu
Journal:  J Neuroinflammation       Date:  2016-04-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.